Skip Navigation Links
July/August 2019Expand July/August 2019
May/June 2019Expand May/June 2019
March/April 2019Expand March/April 2019
January/February 2019Expand January/February 2019
November/December 2018Expand November/December 2018
September/October 2018Expand September/October 2018
July/August 2018Expand July/August 2018
May/June 2018Expand May/June 2018
March/April 2018Expand March/April 2018
January/February 2018Expand January/February 2018
July/August 2017Expand July/August 2017
May/June 2017Expand May/June 2017
March/April 2017Expand March/April 2017
January/February 2017Expand January/February 2017
November/December 2016Expand November/December 2016
July/August 2016Expand July/August 2016
May/June 2016Expand May/June 2016
March/April 2016Expand March/April 2016
January/February 2016Expand January/February 2016
November/December 2015Expand November/December 2015
July/August 2015Expand July/August 2015
May/June 2015Expand May/June 2015
March/April 2015Expand March/April 2015
January/February 2015Expand January/February 2015
ArchiveExpand Archive
November/December 2017Expand November/December 2017
PulseTemplate
September/October 2015Expand September/October 2015
September/October 2016Expand September/October 2016
September/October 2017Expand September/October 2017
Special Edition - EPRExpand Special Edition - EPR
Special Edition: Title V Technical Assistance MeetingExpand Special Edition: Title V Technical Assistance Meeting
Title V Technical Assistance Meeting

 ASTHO Releases State Story on Louisiana 17P Efforts

By Carolyn McCoy, MPH
Senior Policy Manager, Health Reform Implementation, AMCHP
 
The Association of State and Territorial Health Officials (ASTHO) recently released a state story highlighting the efforts of Louisiana to expand use of 17-alphahydroxyprogesterone (17P). 17P is an injectable form of progesterone that has been proven effective in preventing recurrent preterm birth.

In Louisiana, only 5 percent of women who are eligible to receive 17P do so. By linking vital records with Medicaid and creating a Medicaid pay-for-performance measure, the state plans to raise this rate to 20 percent. The State Story highlights: steps taken, including how public health works with Medicaid, results that include data collection improvements and metrics, and lessons learned that can help other states improve use of 17P.

Among many results of the Louisiana work on this topic, they have seen a quadrupling in home injection of 17P and improved collection of data to help track the progress of this effort.

The State Story can be found here: http://www.astho.org/Maternal-and-Child-Health/Louisiana-Public-Health-and-Medicaid-Team-Up-to-Increase-17P-Access-and-Reduce-Preterm-Birth-Rate/.